Italy asked to fully implement EU medicines law to support generic drug competition
This article was originally published in SRA
The European Commission has given Italy two months to fully implement the provisions of the EU medicines legislation on marketing authorisation procedures for generic drugs1. Implementation of the provisions would override an Italian law that currently puts generics manufacturers at a disadvantage on the market.
You may also be interested in...
The EU network of health technology assessment bodies says it is seeing the benefit of systematically involving patients when companies approach it for early scientific advice on evidence generation.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-eight guidance documents have been posted on the tracker since its last update.